Hormone replacement therapy and breast cancer

Estimate of risk

Nathan J. Coombs, Richard Taylor, Nicholas Wilcken, John Boyages*

*Corresponding author for this work

Research output: Contribution to journalReview article

12 Citations (Scopus)


Information about risk of breast cancer with hormone replacement therapy is conflicting Data that can be used to derive individual risk are presented to help decision making Cumulative absolute risk of breast cancer (to 79 years) falls with increasing age in women who do not take hormone replacement therapy Use of hormone replacement therapy increases a woman's cumulative risk only slightly The effect on the general incidence of breast cancer incidence would be greater.

Original languageEnglish
Pages (from-to)347-349
Number of pages3
JournalBritish Medical Journal
Issue number7512
Publication statusPublished - 6 Aug 2005
Externally publishedYes


Cite this

Coombs, N. J., Taylor, R., Wilcken, N., & Boyages, J. (2005). Hormone replacement therapy and breast cancer: Estimate of risk. British Medical Journal, 331(7512), 347-349.